Orthopedic oncology Report 2019 – 2026, Sales Volume, Revenue, Growth Trend and Estimation Forecast

Orthopedic oncology by Procedure Type (Limb salvage surgery, Amputation, Soft tissue resection, Reconstructive surgery, and Adjuvant chemotherapy), By End-User Industries (Cancer Research Institutes and Multispecialty Hospitals), By Region (North America, Europe, APAC and Rest of the World)

LATEST: This report includes COVID 19 Impact Analysis of the Market

  • Report ID : MD1268
  • |
  • Pages : 220
  • |
  • Tables : 82
  • |
  • Formats :

Orthopedic oncology Market revenue shall reach a value of USD Billion in 2026, growing with a CAGR of X.X% during the forecast period of 2018 to 2026. In terms of volume sales, the market is anticipated to reach XX Units.
Orthopedic ontology is a medical problem that is caused due to the formation of tumors in bones and soft connective tissues. It is a quite rare and very serious medical problem and can be treated by constructive surgery. As per a recent orthopedic oncology market research report,12,400 cases of orthopedic oncology across the world came into light. Some of the common oncology tumors are osteosarcoma, Ewing sarcoma, and other malignancies. Annually, about 6,00,000 fracture cases of long bones are stabilized by fixed permanent metal plates and screws in the United States.

Most of the adults were found to be suffering from malignant bone tumors (also known as Chondrosarcoma) across the world. The most prominent challenge with this tumor is its difficulty in diagnosis and treatment. Chemotherapy is not very effective in the case of these tumors. Thus, reconstructive surgery is mainly preferred by doctors. However, this surgery may have its side effects on the human body which is a major restraint for the orthopedic oncology industry growth. As per the recent studies, it is found that  Chondrosarcoma is more prevalent in adults than the 


REGIONAL ANALYSIS

Based on region, the orthopedic oncology industry has been segmented as North America, Europe, Asia Pacific and Rest of the world. Out of which, the North American region has emerged as the dominating region owing to the increasing prevalence of cancer and muscle disorders in this region. After North America, Europe is generating significant market revenue for the last few years and is anticipated to continue the same trend during the forecast period. Also, the Asia Pacific region is anticipated to grow immensely in the coming years. Further, the increasing disposable income of the consumers and increasing awareness among them will drive orthopedic oncology market shares during the forecast period.


SEGMENT ANALYSIS

Segmentation of the orthopedic oncology market has been done based on procedures and end-use industries. By procedure type, the market has been bifurcated as limb salvage surgery, amputation, soft tissue resection, reconstructive surgery, and adjuvant chemotherapy. Out of which, reconstructive surgery emerged as the dominant segment by generating 37% of the overall revenue generated in 2017. Further, a limb salvage procedure is anticipated to grow at a rate of 2.5% during the forecast period. Also, based on end-use industries, the orthopedic oncology market has been segmented as cancer research institutes and multispecialty hospitals. Developing healthcare infrastructure is contributing substantially to the orthopedic oncology market growth.


ORTHOPEDIC ONCOLOGY  COMPANIES:

Amgen Incorporated, Stryker Corporation, Accentus Incorporated, Creganna Medical Group, SiemensHelathineers, Canon Medical Systems, Novartis AG, Sanofi S.A, and MD AndersonCancer Center are the top leading industry players orthopedic oncology. These industry players play a vital role in increasing business revenue by adopting new and advanced strategies. They collaborate with other industries to expand their orthopedic oncology business all over the world.


COVERAGE HIGHLIGHTS    

• Revenue Estimation and Forecast (2018 – 2026)
• Production Estimation and Forecast (2018 – 2026)
• Sales/Consumption Volume Estimation and Forecast (2018 – 2026)
• Breakdown of Revenue by Segments (2018 – 2026)
• Breakdown of Production by Segments (2018 – 2026)
• Breakdown of Sales Volume by Segments (2018 – 2026)
• Gross Margin and Profitability Analysis of Companies
• Business Trend and Expansion Analysis
• Import and Export Analysis
• Regional Analysis and Data Breakdown


SEGMENTAL ANALYSIS

By Procedure Type Outlook ($Revenue and Unit Sales, 2018-2026)
• Limb salvage surgery
• Amputation
• Soft tissue resection
• Reconstructive surgery
• Adjuvant chemotherapy

By End-User Industries Outlook ($Revenue and Unit Sales, 2018-2026)
• Cancer Research Institutes
• Multispecialty Hospitals and

By Regional Outlook ($Revenue and Unit Sales, 2018-2026)
• North America
• Canada
• U.S
• Mexico
• Europe
• Germany
• France
• U.K
• Rest of Europe 
• Asia Pacific
• China
• India
• Japan
• Rest of Asia Pacific
• Rest of the World
• Middle East
• Africa
• Latin America


ORTHOPEDIC ONCOLOGY COMPANIES:

• Amgen Incorporated
• Stryker Corporation
• Accentus Incorporated
• Creganna Medical Group
• Siemens Helathineers
• Canon Medical Systems
• Novartis AG
• Sanofi S.A
• MD Anderson Cancer Center

CHAPTER 1:  INTRODUCTION

1.1. Research Methodology

1.1.1. Desk Research

1.1.2. Data Synthesis

1.1.3. Data Validation & Market Feedback

1.1.4. Data Sources

CHAPTER 2:  EXECUTIVE SUMMARY

2.1. Global Market Outlook

2.2. Core Insights - Procedure

2.3. Core Insights – End-User

2.4. Core Insights – Geography

CHAPTER 3:  MARKET OVERVIEW

3.1.  Market Definition and Scope

3.2. Key Forces Shaping the Industry

3.2.1. Bargaining Power of Suppliers

3.2.2. Bargaining Power of Buyers

3.2.3. Threat of Substitutes

3.2.4. Threat of New Entrants

3.3. Market Dynamics

3.3.1. Drivers

3.3.1.1. Supply-side Drivers

3.3.1.2. Demand-side Drivers

3.3.2. Restraints

3.3.3. Opportunities

3.4. Industry Landscape - PESTEL Analysis

3.4.1. Political Landscape

3.4.2. Environmental Landscape

3.4.3. Social Landscape

3.4.4. Technology Landscape

3.4.5. Economic Landscape

CHAPTER 4:  MARKET BACKGROUND

4.1. Industry Value Chain Analysis

4.1.1. Upstream Participants

4.1.2. Downstream participants

4.2. Pricing Analysis and Forecast, 2018-2026

4.2.1. By Type

4.2.2. By Region

CHAPTER 5:  GLOBAL ORTHOPEDIC ONCOLOGY MARKET, BY PROCEDURE TYPE

5.1. Overview

5.1.1. Market Volume and Forecast, 2018-2026

5.1.2. Market Revenue (US$ Million) and Forecast, 2018-2026

5.2. Limb salvage surgery

5.2.1. Key Market Trends, Growth Factors and Opportunities

5.2.2. Market Volume and Forecast, By Region

5.2.3. Market Revenue (US$ Million) and Forecast, By Region

5.3. Amputation

5.3.1. Key Market Trends, Growth Factors and Opportunities

5.3.2. Market Volume and Forecast, By Region

5.3.3. Market Revenue (US$ Million) and Forecast, By Region

5.4. Soft tissue resection

5.4.1. Key Market Trends, Growth Factors and Opportunities

5.4.2. Market Volume and Forecast, By Region

5.4.3. Market Revenue (US$ Million) and Forecast, By Region

5.5. Reconstructive surgery

5.5.1. Key Market Trends, Growth Factors and Opportunities

5.5.2. Market Volume and Forecast, By Region

5.5.3. Market Revenue (US$ Million) and Forecast, By Region

5.6. Adjuvant chemotherapy

5.6.1. Key Market Trends, Growth Factors and Opportunities

5.6.2. Market Volume and Forecast, By Region

5.6.3. Market Revenue (US$ Million) and Forecast, By Region

CHAPTER 6:  GLOBAL ORTHOPEDIC ONCOLOGY MARKET, BY END-USER

6.1. Overview

6.1.1. Market Volume and Forecast, 2018-2026

6.1.2. Market Revenue (US$ Million) and Forecast, 2018-2026

6.2. Cancer Research Institutes

6.2.1. Key Market Trends, Growth Factors and Opportunities

6.2.2. Market Volume and Forecast, By Region

6.2.3. Market Revenue (US$ Million) and Forecast, By Region

6.3. Multispecialty Hospitals and

6.3.1. Key Market Trends, Growth Factors and Opportunities

6.3.2. Market Volume and Forecast, By Region

6.3.3. Market Revenue (US$ Million) and Forecast, By Region

CHAPTER 7:  GLOBAL ORTHOPEDIC ONCOLOGY MARKET, BY GEOGRAPHY

7.1. Overview

7.2. North America

7.2.1. Key Market Trends, Growth Factors and Opportunities

7.2.2. Market Volume and Forecast, By Procedure

7.2.3. Market Volume and Forecast, By End-User

7.2.4. Market Revenue and Forecast, By Procedure

7.2.5. Market Revenue and Forecast, By End-User

7.2.6. Market Revenue and Forecast, By Country

7.2.7. U.S.

7.2.7.1. Market Volume and Forecast

7.2.7.2. Market Revenue and Forecast

7.2.8. Canada

7.2.8.1. Market Volume and Forecast

7.2.8.2. Market Revenue and Forecast

7.2.9. Mexico

7.2.9.1. Market Volume and Forecast

7.2.9.2. Market Revenue and Forecast

7.3. Europe

7.3.1. Market Volume and Forecast, By Procedure

7.3.2. Market Volume and Forecast, By End-User

7.3.3. Market Revenue and Forecast, By Procedure

7.3.4. Market Revenue and Forecast, By End-User

7.3.5. Market Revenue and Forecast, By Country

7.3.6. Germany

7.3.6.1. Market Volume and Forecast, By Procedure

7.3.6.2. Market Revenue and Forecast, By End-User

7.3.7. UK

7.3.7.1. Market Volume and Forecast, By Procedure

7.3.7.2. Market Revenue and Forecast, By End-User

7.3.8. France

7.3.8.1. Market Volume and Forecast, By Procedure

7.3.8.2. Market Revenue and Forecast, By End-User

7.3.9. Italy

7.3.9.1. Market Volume and Forecast, By Procedure

7.3.9.2. Market Revenue and Forecast, By End-User

7.3.10. Rest of Europe

7.3.10.1. Market Volume and Forecast, By Procedure

7.3.10.2. Market Revenue and Forecast, By End-User

7.4. Asia-Pacific

7.4.1. Market Volume and Forecast, By Procedure

7.4.2. Market Volume and Forecast, By End-User

7.4.3. Market Revenue and Forecast, By Procedure

7.4.4. Market Revenue and Forecast, By End-User

7.4.5. Market Revenue and Forecast, By Country

7.4.6. China

7.4.6.1. Market Volume and Forecast, By Procedure

7.4.6.2. Market Revenue and Forecast, By End-User

7.4.7. India

7.4.7.1. Market Volume and Forecast, By Procedure

7.4.7.2. Market Revenue and Forecast, By End-User

7.4.8. Japan

7.4.8.1. Market Volume and Forecast, By Procedure

7.4.8.2. Market Revenue and Forecast, By End-User

7.4.9. South Korea

7.4.9.1. Market Volume and Forecast, By Procedure

7.4.9.2. Market Revenue and Forecast, By End-User

7.4.10. Rest of Asia-Pacific

7.4.10.1. Market Volume and Forecast, By Procedure

7.4.10.2. Market Revenue and Forecast, By End-User

7.5. REST OF THE WORLD

7.5.1. Market Volume and Forecast, By Procedure

7.5.2. Market Volume and Forecast, By End-User

7.5.3. Market Revenue and Forecast, By Procedure

7.5.4. Market Revenue and Forecast, By End-User

7.5.5. Market Revenue and Forecast, By Country

7.5.6. Latin America

7.5.6.1. Market Volume and Forecast, By Procedure

7.5.6.2. Market Revenue and Forecast, By End-User

7.5.7. Middle East

7.5.7.1. Market Volume and Forecast, By Procedure

7.5.7.2. Market Revenue and Forecast, By End-User

7.5.8. Africa

7.5.8.1. Market Volume and Forecast, By Procedure

7.5.8.2. Market Revenue and Forecast, By End-User

CHAPTER 8:    COMPETITIVE LANDSCAPE

8.1. ORTHOPEDIC ONCOLOGY Market Share Analysis, 2018

CHAPTER 9:    COMPANY PROFILES

9.1. Amgen Incorporated

9.1.1. Company Overview

9.1.2. Financial Performance

9.1.3. SWOT Analysis

9.2. Stryker Corporation

9.2.1. Company Overview

9.2.2. Financial Performance

9.2.3. SWOT Analysis

9.3. Accentus Incorporated

9.3.1. Company Overview

9.3.2. Financial Performance

9.3.3. SWOT Analysis

9.4. Creganna Medical Group

9.4.1. Company Overview

9.4.2. Financial Performance

9.4.3. SWOT Analysis

9.5. Siemens Helathineers

9.5.1. Company Overview

9.5.2. Financial Performance

9.5.3. SWOT Analysis

9.6. Canon Medical Systems

9.6.1. Company Overview

9.6.2. Financial Performance

9.6.3. SWOT Analysis

9.7. Novartis AG

9.7.1. Company Overview

9.7.2. Financial Performance

9.7.3. SWOT Analysis

9.8. Sanofi S.A

9.8.1. Company Overview

9.8.2. Financial Performance

9.8.3. SWOT Analysis

9.9. MD Anderson Cancer Center

9.9.1. Company Overview

9.9.2. Financial Performance

SWOT Analysis

PURCHASE OPTIONS

20% Free Customization ON ALL PURCHASE

*Terms & Conditions Apply

Request Free Sample

Please fill in the form below to Request for free Sample Report

  • Office Hours Mon - Sat   10:00 - 16:00

  • Send Us Mail sales@marketdecipher.com